Rituximab Patients May Benefit from Third COVID-19 Vaccine Dose This abstract will be presented at 10:45am EST, Tuesday, November 9, 2021 during the Late-Breaking Abstracts session (L16 - L21). #ACR21 https://t.co/A1nAL8OnCu https://t.co/lsSyZmjfuF